Australian biopharmaceutical company Cholrem have produced CAVADEX (Beta-Cyclodextrin), a product which removes cholesterol from damaged and narrowed arteries after a few months of treatment, leading to increased blood flow.
Context
Atherosclerosis, also known as heart disease, is reportedly the western world’s number one killer of people. This disease results from the accumulation of cholesterol in the arteries. Until now, the only drugs to combat this condition are statins and cholesterol lowering drugs that may slowly reduce plaque over years if combined with strict lifestyle changes.
Official comments
Cholrem CEO Kyle Hodgetts said: “I developed this treatment to save my own life. After the first month of treatment my cholesterol levels were dramatically reduced and there was substantial improvement in my liver function, and within another month CAVADEX significantly reduced the blockages in my arteries.”
Professor Laurie Howes, a researcher in preventative cardiology and pharmacology, commented: “I have managed Kyle’s cardiovascular problems over at least 10 years, we have had disagreements about his management and especially his lifestyle. Conventional cholesterol treatments along with lifestyle changes can reverse blockages in arteries, but it is a slow process over many years. I have never seen such dramatic effects and results over a matter of months. It is definitely a major priority for further research. His results replicate in humans those achieved in clinical experiments around 2016”.
The study
Cholrem conducted more studies and the results showed that patients who administered CAVADEX daily demonstrated reduced cholesterol levels and plaque reduction within two months.
Beta-Cyclodextrin is a natural sugar-based compound formed from lactobacilli, approved by the FDA and has been used for decades in the production of low-fat foods and is also used to help dissolve drugs for delivery to the body.
Blood circulation delivers oxygen and nutrients to every part of the body and collects carbon dioxide and other metabolic products to be excreted from the body. The main vessels clog with cholesterol and the microscopic vessels are restricted, degrading the body as it ages. Research done by the University of Texas Southwest Medical Center shows that treating mice with cyclodextrin significantly prolonged their lives.
